Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Farrell

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|February 20, 2014
Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance programRodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014Helio S Sader, Robert K Flamm, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2010
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, ItalyRodrigo E Mendes, Lalitagauri M Deshpande, David J Farrell, et al.
Anaerobe|June 14, 2014
Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011Alex Marchand-Austin, Prasad Rawte, Baldwin Toye, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2007
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylationNicole Wolter, Anthony M Smith, David J Farrell, et al.
International Journal of Antimicrobial Agents|June 14, 2016
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014)Helio S Sader, Mariana Castanheira, David J Farrell, et al.
International Journal of Antimicrobial Agents|May 10, 2015
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumoniaHelio S Sader, Mariana Castanheira, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2016
Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potencyRodrigo E Mendes, Mariana Castanheira, David J Farrell, et al.
International Journal of Antimicrobial Agents|February 7, 2012
Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumoniaDouglas J Biedenbach, David J Farrell, Robert K Flamm, et al.
International Journal of Antimicrobial Agents|March 10, 2010
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolatesDavid J Farrell, Helio S Sader, Mariana Castanheira, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|February 20, 2014
Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance programRodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014Helio S Sader, Robert K Flamm, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2010
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, ItalyRodrigo E Mendes, Lalitagauri M Deshpande, David J Farrell, et al.
Anaerobe|June 14, 2014
Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011Alex Marchand-Austin, Prasad Rawte, Baldwin Toye, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2007
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylationNicole Wolter, Anthony M Smith, David J Farrell, et al.
International Journal of Antimicrobial Agents|June 14, 2016
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014)Helio S Sader, Mariana Castanheira, David J Farrell, et al.
International Journal of Antimicrobial Agents|May 10, 2015
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumoniaHelio S Sader, Mariana Castanheira, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2016
Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potencyRodrigo E Mendes, Mariana Castanheira, David J Farrell, et al.
International Journal of Antimicrobial Agents|February 7, 2012
Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumoniaDouglas J Biedenbach, David J Farrell, Robert K Flamm, et al.
International Journal of Antimicrobial Agents|March 10, 2010
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolatesDavid J Farrell, Helio S Sader, Mariana Castanheira, et al.
Pageof 18